Every day, in operating rooms around the world, surgeons are faced with challenging repairs and reconstructions of soft tissues in cancer, trauma, and hernia patients. For their most challenging repairs, surgeons choose TEI Biosciences’ novel biologic products for superior clinical outcomes.
Bovine vs Porcine Acellular Dermal Matrix for Complex Abdominal Wall Reconstruction.
American Society of Plastic and Reconstructive Surgery Learn More
Improvement of Success Rates for Abdominal Component Reconstructions Using Bovine Fetal Collagen
Annals of Plastic Surgery Learn More
TEI Biosciences’ products have been studied in a broad range of clinical applications. Peer reviewed and published clinical references are listed here, grouped by clinical application. Learn More
News + Events
February 24, 2015
TEI Biosciences Inc. (“TEI”), a leading biomedical company that applies its expertise in regenerative medicine to develop and commercialize novel biologic devices for a broad spectrum of soft tissue repair and regeneration applications, announced today that it has signed a national agreement with Novation, the nation’s leading health care services company.